Globally, 7000 neonatal deaths occur every day, most in the first week of life. Adolescence represents a critical period in health. Navigating it well sets the individual on a healthier life course, enabling full and productive contribution to society. Adolescents are exposed to considerable risks, including in sexual health, HIV, exposure to drugs, and increased occupational and environmental hazards.
In 2015, 70% of global deaths were due to NCDs. Our research highlights the importance of this category of illness, closely related to aging societies everywhere. Moreover, our projects explicitly acknowledge the disproportionate NCD burden among lower income countries and populations linked to ageing, globalization of life-styles and rapid urbanization.
Our work highlights the health challenges of a fast-changing global society. Our global health research projects have a strong emphasis on the health consequences of a changing world, including climate change, ageing populations, rapid urbanisation, globalization of life-styles, and the social, economic and political determinants of health. We seek to mitigate hazards that do not respect national boundaries and as such the risks of inaction and the benefits of innovation are shared by all.
Infectious diseases remain a hugely important health issue globally, and the main cause of death. Prevention, preparedness, early detection, treatment, cure and elimination of most major diseases have still not been achieved. Our work addresses the “unfinished business” with respect to the control of infectious diseases.
Safe and cost-effective health technologies and tools are needed to improve population health on a large scale. These are innovations developed for low-resource settings, which can eventually be contributing to the sustainability of health care systems. EGHRIN highlights the importance of research addressing the implications of commercialisation of health for patients, health care providers and health systems.
Our research aims at harnessing the Global Public Health research expertise to study models and approaches for health and care in a wide variety of settings including those in low resource regions.
The Barcelona Institute for Global Health, ISGlobal, is the fruit of an innovative alliance between the “la Caixa” Foundation”, academic institutions and government bodies to contribute to the efforts undertaken by the international community to address the challenges in global health.ISGlobal is a consolidated hub of excellence in research that has grown out of work first started in the world of health care by the Hospital Clínic and the Parc de Salut MAR and in the academic sphere by the University of Barcelona and Pompeu Fabra University.
Its ultimate goal is to help close the gaps in health disparities between and within different regions of the world.
The Amsterdam Institute for Global Health and Development (AIGHD) is an international research and education institute that works to develop sustainable solutions to major health problems. AIGHD was initiated as a partnership between the Amsterdam University Medical Centers (AUMC), the University of Amsterdam (UvA) and the Vrije Universiteit Amsterdam (VU). AIGHD is a dynamic research and education institute that thrives on intense collaboration among experts from multiple disciplines including biomedicine, economics and social and behavioral sciences. With its interdisciplinary and translational approach, AIGHD addresses the most critical medical, social, economic and political challenges in global health and development that cut across national and political borders. www.aighd.org
The Heidelberg Institute of Global Health (HIGH) is one of the research institutes in the Faculty of Medicine at the University of Heidelberg, Germany’s oldest university. Through its research, the institute aims to contribute to improving the health of some of the sickest and poorest populations worldwide, especially in Africa and Asia.Through its teaching, the institute aims to train the next generation of global health researchers and practitioners. The research projects at the institute focus on Identifying important disease risk factors and health care needs, Discovering new approaches to improving population health, Establishing novel models of providing health care https://www.klinikum.uni-heidelberg.de/HIGH.5358.0.html
The LMU Munich is actively strengthening its global health profile within the Faculty of Medicine through the CIHLMU Center for International Health and, increasingly, across different Faculties. The CIHLMU has been founded in 2009 as an interdisciplinary entity with the aim to empower health professionals in low- and middle-income countries through targeted teaching and training interventions. Two major drivers behind an increasing focus on global health at the LMU Munich are the Division of Infectious Diseases & Tropical Medicine with its focus on infectious diseases through basic, applied clinical and translational research as well as humanitarian aid in low- and middle-income countries; and the Pettenkofer School of Public Health with its broad public health approach and emphasis on determinants of health in countries around the globe. www.cih.lmu.de
The primary areas of research of the center in Lund are sexual and reproductive health and rights, maternal and child health, youth health, social capital, health policy, marginalized populations, mental health, violence, substance abuse, risk factors for chronic disease, and environmental stress. A key focus is to utilize accumulated knowledge to provide expertise for interventions in order to improve health and health systems. www.lunduniversity.lu.se
The George Institute for Global Health is a health and medical research institute with a mission is to improve the health of millions of people worldwide. Our researchers in Oxford are using large-scale datasets from across the world – big data – to better understand chronic disease patterns and to determine how to improve health services and identify cost-effective treatments in priority areas like women’s and children’s health, cardiovascular disease, diabetes and cancer. The George Institute has been affiliated with the University of Oxford since 2010, and has offices in China, India and Australia, where it was established in 1999. georgeinstitute.org.uk Twitter feed: @GeorgeInstUK
Julius Global Health is part of the University Medical Center Utrecht in The Netherlands. Julius carries out research and educational activities in the field of reproductive & child health, cancer, diabetes & cardiovascular epidemiology, infectious diseases and environmental health. https://www.globalhealth.eu
Imperial College houses the Institute of Global Health Innovation, which conducts research in the following areas: Maternal and child health, Communications technology and health, Engineering and global health,Health and the environment, Infectious diseases, Neglected tropical disease, Chronic and non-communicable diseases, and Health management https://www.imperial.ac.uk/global-health-innovation/
ITM conducts, within a coherent academic triad, fundamental, translational and applied scientific research; delivers advanced education and training; and provides medical, scientific and societal expert services. ITM strives in the fulfilment of its mission for excellence, integrity, specificity and efficiency. It upholds human dignity and diversity, academic creativity and critical sense, solidarity and collaboration, and the well-being of its employees, students, patients and other clients. https://www.itg.be
The Institute for Global Health at UCL provides a unique, cross-disciplinary approach throughout their research and teaching activities. UCL works in the real world, collaborating with communities at all levels, and offering workable solutions for policy makers. The Institute for Global Health implements UCL’s Grand Challenge of Global Health, a cross disciplinary initiative to provide innovative, workable solutions to global health problems. https://www.ucl.ac.uk/igh
LUMC acts as a knowledge centre for topics in the field of public and global health with an impact on society, it has a directive function in the region and it acts as a centre for continuing education and further training for medical professionals. The collaboration between LUMC, Leiden University and the Leiden Bioscience Park creates unique possibilities for medical innovation in Leiden and the surrounding area. https://www.lumc.nl/
The University of Milan is a public, multidisciplinary teaching and research institution that offers 8 Faculties, 2 Schools, 136 study courses, 31 Doctoral Programmes and 63 Specialisation Schools. It houses the new Centre for Multidisciplinary Research in Health Science (MACH), that is an international landmark and leading centre for health research with a special, but not exclusive, interest in infectious diseases within a global and multidisciplinary perspective. Within MACH, global health is prioritised through a centre devoted to global health didactics and research.
The Institute of Global Health was founded in January 2014 as a transformation of the former Institute of Social and Preventive Medicine. This transformation was decided by the University of Geneva as a continuation of efforts to develop academic global health given the unique location of Geneva in the field. Geneva hosts most of the major actors of global health: the World Health Organization, UNAIDS, the Global Fund to fight AIDS, Tuberculosis and Malaria, ICRC, GAVI, FIND, MSF and many other NGOs and foundations, with diplomatic permanent UN representations for more than 140 countries. The creation of the Institute of Global Health was inspired by a shared commitment to foster academic Global Health at the Faculty of Medicine of the University of Geneva. It is located in the facilities of Campus Biotech shared by the University of Geneva and Ecole Polytechnique Fédérale de Lausanne (EPFL). https://www.unige.ch/medecine/isg/en
The Human Vaccines Project Europe (HVPE) contributes to the overall objective of the
global Human Vaccines Project to decode the human immune system and to accelerate the
development of vaccines, immunotherapies and diagnostics to prevent, treat and
cure important diseases. The Human Vaccines Project Europe focusses on outreach, advocacy, fundraising, creating partnerships and consortia to shape and strengthen the European contribution to the global research program.
https://www.humanvaccinesproject.org/wp-content/uploads/2020/01/HVPEurope_ANBI-status_Jan2020.pdf
Director General of the Barcelona Institute for Global Health
Training & Education Director ISGlobal, Barcelona, Spain
Director, UCL Institute for Global Health and Professor of Infectious Disease Epidemiology
Chair of Public Health and Health Services Research at the Pettenkofer School of Public Health at the LMU Munich
Chair, Executive Board, AIGHD;Professor of Global Health, Department of Global Health, Amsterdam UMC, University of Amsterdam
Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg
Director Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg.
Full Professor of Global Health, Centre for Multidisciplinary Research in Health Science (MACH), Università di Milano, Milan, Italy
Director of the Tropical Institute of Munich (LMU), and founding member of the Center for International Health
Co-founder and Principal Director of The George Institute for Global Health.
Deputy Director of The George Institute for Global Health at the University of Oxford.
Senior Advocacy Advisor at The George Institute for Global Health
Senior lecturer and researcher at the Tropical Insitute University of Munich (LMU)
Director of the Institute of Global Health, University of Geneva, Switzerland
Associate Professor and Academic Coordinator Global Health, UMC Utrecht, The Netherlands
Professor of Economics, UCL Institute for Global Health, London, UK
Chief Scientific Adviser and Hon. Senior Clinical Fellow in Surgery, Institute of Global Health Innovation, Imperial College London
Vice Rector Research Policy
Business Development AIGHD, Board member BEAM Alliance, Program Director INDIGO project for Affordable and Effective Influenza Vaccines